For research use only. We do not sell to patients.
CDK9-IN-1
CAS No. : 1415559-43-1
Biological Activity：CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection, with an IC50 of 39 nM for CDK9/CycT1, extracted from reference, compound 87.
Research Area：Infection
Targets：CDK|HIV
Related Screening Libraries:Bioactive Compound Library Plus;Anti-Infection Compound Library;Cell Cycle/DNA Damage Compound Library;Kinase Inhibitor Library;Antiviral Compound Library;Anti-Aging Compound Library;Anti-Breast Cancer Compound Library;Anti-Blood Cancer Compound Library;Human Metabolite Library;Cancer Stem Cells Compound Library;
Related Small Molecules:DB0614;Dinaciclib;HIV-1 TAT (48-60);Seletracetam lithium;SNS-032;HIV-IN-2;CC-671;(E/Z)-Zotiraciclib;Triptonine B;CDK1-IN-4;CCT-251921;FC131;Peritassine A;BS-181;Samuraciclib hydrochloride hydrate;T025;Flavopiridol;CDK8-IN-3;TAT (48-57);CDK9-IN-12;FGI-106 tetrahydrochloride;FLT3/CDK4-IN-1
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
